STORM in the News
CEO Keith Blundy spoke to Wuxi AppTec about STORM Therapeutics trailblazing research into RNA modifying enzymes as part of its “Innovation that Matters” series.
Read more
STORM was featured as one of the top companies taking on RNA modification in 2018
Read more
Tony Kouzarides spoke to BioCentury about founding STORM Therapeutics Limited and how academics connect with the biotech industry to build companies.
Read more
Tony Kouzarides co-authored scientific paper on METTL1, published in Molecular Cell.
Read more
Richard A. Stein spoke to Keith Blundy about Developing RNA-Level Epigenetic Therapeutics
Read more